Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-VEGF Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07427719
What this trial is testing

Retinopathy of Prematurity - Visual Function and Retinal Structure

Who this might be right for
Retinopathy of Prematurity (ROP)Prematurity ComplicationsCerebral Visual Impairment+1 more
Oslo University Hospital 140
Post-approval studies (Phase 4)WithdrawnNCT04075136
What this trial is testing

Optical Coherence Tomography Angiography (OCTA) - Directed PDT Triple Therapy

Who this might be right for
Exudative Age Related Macular Degeneration
Wake Forest University Health Sciences
Post-approval studies (Phase 4)Study completedNCT04674254
What this trial is testing

Macular Perfusion Changes After Anti-VEGF Versus Targeted Retinal Photocoagulation in Proliferative Diabetic Retinopathy

Who this might be right for
Proliferative Diabetic RetinopathyVascular Endothelial Growth Factor OverexpressionDiabetic Retinopathy
Cairo University 43
Post-approval studies (Phase 4)Study completedNCT01710839
What this trial is testing

Widefield Angiography Guided Targeted-retinal Photocoagulation Combined With Anti VEgf Intravitreal Injections for the Treatment of Ischemic Central Retinal Vein Occlusion, Hemi Retinal Vein Occlusion, and Branch Retinal Vein Occlusion

Who this might be right for
Central Retinal, Hemi Retinal & Brach Retinal Vein Occlusions
Charles C Wykoff, PhD, MD 30
Testing effectiveness (Phase 2)UnknownNCT03973112
What this trial is testing

A Clinical Study Evaluating the Use of HLX10 in Combination With HLX04 for the Treatment of Advanced Hepatocellular Carcinoma (HCC) Patients

Who this might be right for
Hepatocellular Carcinoma
Shanghai Henlius Biotech 123
Not applicableActive Not RecruitingNCT06717139
What this trial is testing

Recurrence and Predictive OCT Biomarkers in Quiescent Neovascular AMD

Who this might be right for
Retinal DiseasesMacular DegenerationNeovascular (Wet) Age-Related Macular Degeneration
St. Erik Eye Hospital 220
Early research (Phase 1)Study completedNCT00454649
What this trial is testing

Investigational Agent AG-013736 In Combinations With Standard Of Care Treatments For Patient's With Advanced Solid Tumor

Who this might be right for
Neoplasms
Pfizer 102
Not applicableWithdrawnNCT01159236
What this trial is testing

Molecular Triaging of Newly Diagnosed Breast Cancer

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT02712008
What this trial is testing

Anti-vasculaR Endothelial Growth Factor plUs Anti-angiopoietin 2 in Fixed comBination therapY: Evaluation for the Treatment of Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
Regeneron Pharmaceuticals 302
Post-approval studies (Phase 4)Ended earlyNCT04707625
What this trial is testing

Vascular Endothelial Growth Factor (VEGF) Levels in Retinal Vein Occlusion (RVO) During Anti-VEGF Treatment

Who this might be right for
Retinal Vein Occlusion
Wake Forest University Health Sciences 17
Early research (Phase 1)Ended earlyNCT01004822
What this trial is testing

A Safety, Tolerability, And Pharmacokinetic Trial With CVX-241 In Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Pfizer 31
Testing effectiveness (Phase 2)Ended earlyNCT00749567
What this trial is testing

Combination of Erlotinib and Bevacizumab as Second-line Treatment in Patients With Non-small Cell Lung Cancer

Who this might be right for
Non-small-cell Lung Cancer
Hellenic Oncology Research Group 13
Not applicableStudy completedNCT01025063
What this trial is testing

Use of Spectral OCT in Combination Therapy

Who this might be right for
Choroidal Neovascularization
Barnes Retina Institute 15
Post-approval studies (Phase 4)Study completedNCT03590444
What this trial is testing

Treatment of Diabetic Macular Edema (DME) With Anti-VEGF and Focal Laser

Who this might be right for
Diabetic Retinal Edema
Hospital Hietzing 50
Not applicableStudy completedNCT03345667
What this trial is testing

Assessment of Color Vision in Diabetic Patients

Who this might be right for
Retinopathy, Diabetic
Instituto de Olhos de Goiania 30
Not applicableStudy completedNCT01771081
What this trial is testing

Evaluation of Changes in Visual Acuity in Patients With Diabetic Macular Edema (DME) Starting Treatment With an Approved Anti-VEGF Therapy

Who this might be right for
OphthalmologyMacular EdemaMacular Degeneration
Bayer 911
Not applicableStudy completedNCT01947881
What this trial is testing

Characterization of Eyes With Diabetic Macular Edema That Show Different Treatment Response to Intravitreal Anti-VEGF (CHARTRES)

Who this might be right for
Diabetic Macular Edema
Association for Innovation and Biomedical Research on Light and Image 71
Testing effectiveness (Phase 2)Study completedNCT01180959
What this trial is testing

Erlotinib Plus Bevacizumab in Hepatocellular Carcinoma (HCC) as Second-line Therapy

Who this might be right for
Liver Cancer
M.D. Anderson Cancer Center 45
Not applicableStudy completedNCT00978926
What this trial is testing

The Pharmacodynamic Effects of Anti-Vascular Endothelial Growth Factor Therapy in Patients With Advanced Malignancies

Who this might be right for
Advanced Malignancy
National University Hospital, Singapore
Testing effectiveness (Phase 2)Study completedNCT04304755
What this trial is testing

Zoledronic Acid as Adjuvant Therapy in Neovascular Age-related Macular Degeneration (Z-AMD)

Who this might be right for
Neovascular Age-related Macular Degeneration
Oslo University Hospital 40
Next Page